The city of Hartford, Connecticut, currently has 13 active clinical trials seeking participants for Breast Cancer research studies.
Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation
Recruiting
The purpose of this study is to find out how often the researchers can avoid an ALND in patients with early-stage, node-positive HR+/HER2- breast cancer who are having upfront surgery. The study researchers think that, if AUS before surgery can help identify people who may have up to 3 affected lymph nodes, it will be possible to perform the less radical standard SLNB during surgery.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/29/2024
Locations: Hartford Healthcare Cancer Alliance (Data collection only), Hartford, Connecticut
Conditions: Breast Cancer